| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 08/07/2003 | US20030148508 Recombinant phages capable of entering host cells via specific interaction with an artificial receptor |
| 08/07/2003 | US20030148506 Preparing genetically engineered parvoviral particles in insect cells; gene therapy |
| 08/07/2003 | US20030148496 Cell-free system for translation and formation of HTLV lymphadenopathy associated viral coat proteins; viricides; drug screening |
| 08/07/2003 | US20030148348 Self-replicating RNA molecule from hepatitis C virus |
| 08/07/2003 | US20030148325 Infectious clones |
| 08/07/2003 | US20030148268 By identifying bacterial cell wall substrates that bind the binding domain of bacteriophage lysins |
| 08/07/2003 | US20030148265 The factor allowing translocation is the homeodomain of antennapedia, and the viral protein can be from Flavivirus; fusion proteins as therapeutic agents |
| 08/07/2003 | US20030148262 Chimeric alphavirus replicon particles |
| 08/07/2003 | US20030147919 Producing empty, and thus non-infectious, parvovirus capsids, and to diagnostic assays and vaccines utilizing same; packaging and transferring nucleic acids |
| 08/07/2003 | US20030147917 Retrovirus from the HIV group and its use |
| 08/07/2003 | US20030147916 Recombinant influenza a viruses |
| 08/07/2003 | US20030147907 Retroviral vectors |
| 08/07/2003 | US20030147854 Adenovirus vectors for gene therapy |
| 08/07/2003 | US20030147853 Recombinant adeno-associated virus-mediated gene transfer via retroductal infusion of virions |
| 08/07/2003 | US20030147852 Toxin-phage bacteriocide antibiotic and uses thereof |
| 08/07/2003 | CA2474810A1 Methods for retrotransposing long interspersed elements (lines) |
| 08/07/2003 | CA2474777A1 Adenoviral vectors for modulating the cellular activities associated with pods |
| 08/07/2003 | CA2474339A1 Multiple virus replicon culture systems |
| 08/07/2003 | CA2464138A1 Methods of preventing and treating flavivirus infection in animals |
| 08/06/2003 | EP1332218A1 Differentiation-inducing substances |
| 08/06/2003 | EP1332217A2 Novel bacterial phytases and method for producing same |
| 08/06/2003 | CN1434870A Viral core protein-cationic lipid-nucleic acid-delivery complexes |
| 08/06/2003 | CN1434831A Improvments in or relating to immune responses to HIV |
| 08/06/2003 | CN1117156C Non self-inactivating, expression targeted retroviral vectors |
| 08/06/2003 | CN1117146C Hypotonic strain for virus of young parakeet |
| 08/05/2003 | US6602706 Cell comprising nucleotide sequence encoding viral gene product and recombinant nucleic acids lacking overlapping sequences; virus unable to replicate; use in treatment of genetic disorders and autoimmune diseases; antitumor agent |
| 08/05/2003 | US6602705 Expression of HIV polypeptides and production of virus-like particles |
| 08/05/2003 | US6602697 Process for purifying human papillomavirus virus-like particles |
| 08/05/2003 | US6602505 Polynucleotide comprising caprine arthritis encephalitis virus (CAEV) viral genome renders nonpathogenic to a primate a resulting retroviral particle produced via gene expression, generating immune response against HIV-1 |
| 08/05/2003 | US6602499 Viral mutants for selectively killing neoplastic cells; herpes simplex virus vector; transgene encoding cytochrome P450, chemotherapeutic agent activated by cytochrome P450; viral mediated oncolysis and anticancer "suicide" gene therapy |
| 08/05/2003 | US6602498 Water soluble polymer backbone such as polyethylene glycol, endcapped with a N-maleimidyl moiety without using a linker; conjugated peptides, proteins, nucleotides and drugs |
| 07/31/2003 | WO2003062424A1 Nucleic acid sequence comprising the rna packaging signal of a group 1 coronavirus and the applications thereof |
| 07/31/2003 | WO2003062408A1 Virus-like particles |
| 07/31/2003 | WO2003062407A1 INFECTIOUS cDNA CLONES OF PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS AND EXPRESSION VECTORS THEREOF |
| 07/31/2003 | WO2003062400A2 Fiber shaft modifications for efficient targeting |
| 07/31/2003 | WO2003062377A2 COMPLETE GENOME SEQUENCE OF SIVcpzTAN1 |
| 07/31/2003 | WO2003061582A2 Generation of recombinant adeno-associated viral vectors by a complete adenovirus-mediated approach |
| 07/31/2003 | WO2003061555A2 West nile vaccine |
| 07/31/2003 | US20030143730 The viral DNA is introduced into a culture of encapsidation cells and the viruses produced are harvested following release into the supernatant such as by ultrafiltration; use of iodixanol for purification of adenoviruses |
| 07/31/2003 | US20030143710 Protein corresponding to recombinant fungal epoxide hydrolase; use making enantiomerically pure diols and/or epoxides |
| 07/31/2003 | US20030143573 Detection of bovine viral diarrhea virus in tissue samples |
| 07/31/2003 | US20030143562 Structurally biased random peptide libraries based on different scaffolds |
| 07/31/2003 | US20030143526 Recombinanr hhv8 dna |
| 07/31/2003 | US20030143248 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof |
| 07/31/2003 | US20030143247 For therapy of infections with hepatitis or picornaviruses |
| 07/31/2003 | US20030143209 For gene therapy of cancers or cardiovascular conditions |
| 07/31/2003 | US20030143201 For inducing protective immune response, thereby enhancing protection of the individual against subsequent infection by western equine encephalitis virus |
| 07/31/2003 | US20030143200 Porcine adenovirus E1 region |
| 07/31/2003 | US20030143190 For modulating the immune system; therapy of cancer |
| 07/31/2003 | CA2474763A1 Fiber shaft modifications for efficient targeting |
| 07/31/2003 | CA2452545A1 West nile vaccine comprising live attenuated, inactivated or killed whole or subunit west nile virus |
| 07/30/2003 | EP1331270A1 Novel recombinant feline herpesvirus 1 and polyvalent vaccine with the use of the same |
| 07/30/2003 | EP0833923B1 Immunogenic construct, process for its preparation and use as a vaccine |
| 07/30/2003 | EP0768824B1 Insect control method with genetically engineered biopesticides |
| 07/30/2003 | CN1433476A Permanent amniocyte cell line, the production thereof and its use for producing gene transfer vectors |
| 07/30/2003 | CN1433472A Production of vaccines |
| 07/30/2003 | CN1433465A Method for preservation of viruses and mycorplasma |
| 07/30/2003 | CN1433430A Hepatitis virus sentinel virus I (SVI) |
| 07/29/2003 | US6600023 Antibody directed against HIV-1 P25 antigen |
| 07/29/2003 | US6599739 Papillomavirus viral vector for use in the transfer of nucleotide sequences |
| 07/29/2003 | US6599738 Reporter gene system for use in cell-based assessment of inhibitors of the hepatitis C virus protease |
| 07/29/2003 | US6599699 Methods for diagnosing a disorder by assaying for MAGE-3 |
| 07/29/2003 | US6599698 Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy |
| 07/29/2003 | US6599508 Truncated papillomavirus L1 protein, vaccine |
| 07/29/2003 | CA2189971C Vaccine for moraxella catarrhalis |
| 07/24/2003 | WO2003060106A1 Method and device for identifying substances capable of modulating adipocyte differentiation |
| 07/24/2003 | WO2003060101A2 Gene delivery system and methods of use |
| 07/24/2003 | WO2003060088A2 Viral vaccine production method |
| 07/24/2003 | WO2003059944A2 Gb virus b based replicons and replicon enhanced cells |
| 07/24/2003 | WO2003059292A2 Composition and method for maintaining non-enveloped viral vectors |
| 07/24/2003 | US20030140377 DNA encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5A, transgenic plants and a method for controlling senescence programmed and cell death in plants |
| 07/24/2003 | US20030138954 Self-inactivating plasmid/vector; gene therapy; treating hematological disorders; anticarcinogenic agents |
| 07/24/2003 | US20030138922 Therapy of stealth virus associated cancers and other conditions using magnetic energy |
| 07/24/2003 | US20030138916 Infectious cDNA clones of porcine reproductive and respiratory syndrome virus and expression vectors thereof |
| 07/24/2003 | US20030138772 Polymerase chain reactions to screen and isolate parvovirus DNA obtained from tissue and/or cells without coinfection by helper viruses; gene therapy |
| 07/24/2003 | US20030138457 Such as F protein of Paramyxovirus SV5 strain; this recombinant Rhabdovirus may express other non-Rhabdovirus attachment proteins and/or an enhancer protein; for diagnostic and therapeutic compositions for treatment of diseases |
| 07/24/2003 | US20030138456 Vaccines expressed in plants |
| 07/24/2003 | US20030138453 Microparticles comprise a polymer such as a poly(alpha-hydroxy acid), polyhydroxy butyric acid, polycaprolactone, a polyorthoester, a polyanhydride, formed using cationic, anionic, or nomonic detergents; drug delivery |
| 07/24/2003 | US20030138442 Protein- or polynucleic acid-based vaccine which protects a pig against porcine reporductive and respiratory syndrome |
| 07/24/2003 | US20030138405 An adenovirus encoding an E1A polypeptide unable to bind the tumor suppressor protein retinoblastomas (Rb) may replicate in or kill a cell having a defective Rb pathway but not the non-mutant cells; gliomas; gene therapy; antitumor agents |
| 07/24/2003 | CA2472759A1 Gb virus b based replicons and replicon enhanced cells |
| 07/24/2003 | CA2472016A1 Method and device for identifying substances capable of modulating adipicyte differentiation |
| 07/23/2003 | EP1328625A2 Dermatophagoides nucleic acid molecules, proteins and uses thereof |
| 07/23/2003 | EP1328542A1 Von willebrand factor-binding proteins from staphylococci |
| 07/23/2003 | EP1328291A2 Viruses targeted to hypoxic cells and tissues |
| 07/23/2003 | EP0670905B1 Recombinant viruses displaying a nonviral polypeptide on their external surface |
| 07/23/2003 | CN1431913A Vaccine compsn. |
| 07/23/2003 | CN1431864A Vaccines, immunotherapeutics and methods for using same |
| 07/23/2003 | CN1115414C Virus carrier used for gene therapy |
| 07/23/2003 | CN1115411C Virus-deactivating method |
| 07/22/2003 | US6596926 Isolated polynucleotide comprising nucleotide sequence encoding a polypeptide having phosphatidylethanolamine N-methyltransferase activity |
| 07/22/2003 | US6596539 Modification of virus tropism and host range by viral genome shuffling |
| 07/22/2003 | US6596535 Adeno-associated viral vector for use as tool in the transfer of genetic information for use in the treatment of arthritis |
| 07/22/2003 | US6596533 Polypeptide for use in the treatment of infections and cell proliferative disorders |
| 07/22/2003 | US6596529 Manipulation of negative stranded RNA viruses by rearrangement of their genes and uses thereof |
| 07/22/2003 | US6596485 Fusion proteins capapble of presenting the peptide in a conformationally restricted form; use in screening peptide libraries |
| 07/22/2003 | US6596280 Live bimavirus such as infectious bursal disease virus |
| 07/22/2003 | US6596279 Immunodeficiency recombinant poxvirus |
| 07/22/2003 | US6596268 Viruses for the treatment of cellular proliferative disorders |
| 07/22/2003 | US6596172 Purification of biological substances |